Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism
Young Jae Bahn, … , Alexandra C. McPherron, Sushil G. Rane
Young Jae Bahn, … , Alexandra C. McPherron, Sushil G. Rane
Published July 3, 2023
Citation Information: J Clin Invest. 2023;133(13):e162479. https://doi.org/10.1172/JCI162479.
View: Text | PDF
Research Article Metabolism Muscle biology

CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism

  • Text
  • PDF
Abstract

Understanding how skeletal muscle fiber proportions are regulated is vital to understanding muscle function. Oxidative and glycolytic skeletal muscle fibers differ in their contractile ability, mitochondrial activity, and metabolic properties. Fiber-type proportions vary in normal physiology and disease states, although the underlying mechanisms are unclear. In human skeletal muscle, we observed that markers of oxidative fibers and mitochondria correlated positively with expression levels of PPARGC1A and CDK4 and negatively with expression levels of CDKN2A, a locus significantly associated with type 2 diabetes. Mice expressing a constitutively active Cdk4 that cannot bind its inhibitor p16INK4a, a product of the CDKN2A locus, were protected from obesity and diabetes. Their muscles exhibited increased oxidative fibers, improved mitochondrial properties, and enhanced glucose uptake. In contrast, loss of Cdk4 or skeletal muscle–specific deletion of Cdk4’s target, E2F3, depleted oxidative myofibers, deteriorated mitochondrial function, and reduced exercise capacity, while increasing diabetes susceptibility. E2F3 activated the mitochondrial sensor PPARGC1A in a Cdk4-dependent manner. CDK4, E2F3, and PPARGC1A levels correlated positively with exercise and fitness and negatively with adiposity, insulin resistance, and lipid accumulation in human and rodent muscle. All together, these findings provide mechanistic insight into regulation of skeletal muscle fiber–specification that is of relevance to metabolic and muscular diseases.

Authors

Young Jae Bahn, Hariom Yadav, Paolo Piaggi, Brent S. Abel, Oksana Gavrilova, Danielle A. Springer, Ioannis Papazoglou, Patricia M. Zerfas, Monica C. Skarulis, Alexandra C. McPherron, Sushil G. Rane

×

Figure 2

Cdk4R/R muscles display increased oxidative fibers without change in glycolytic fiber composition.

Options: View larger image (or click on image) Download as PowerPoint

Cdk4R/R muscles display increased oxidative fibers without change in gl...
(A) Lean mass and (B) total muscle fiber numbers in Cdk4R/R mice compared with those in Cdk4WT mice. (C) mRNA levels of myosin isoforms in quadriceps (QA) muscles of Cdk4WT and Cdk4R/R mice (n = 6 mice each group). (D) Heatmap of RNA-Seq analysis of QA muscle transcripts in Cdk4WT and Cdk4R/R mice (n = 3 mice each group). Upregulated (Up) mRNAs are indicated with a blue bar. (E) Gene ontology (GO) analysis of upregulated genes in QA muscles of Cdk4WT and Cdk4R/R mice. (F) Log2 fold change RNA-Seq values of type I fiber markers in QA muscles of Cdk4WT and Cdk4R/R mice. (G) Immunofluorescence and (H) quantification of slow/oxidative fibers (MyhcI and MyhcIIa) and fast/glycolytic fibers (MyhcIIx and MyhcIIb) in QA muscles of Cdk4WT and Cdk4R/R mice. Scale bars: 200 μm. (I) Histochemistry staining and (J) quantification of metabolically active SDH-positive fibers in TA muscles of Cdk4WT and Cdk4R/R mice (n = 5 mice each group). Scale bars: 500 μm. (K) Expression of MyHC, Pgc-1α and Uqcrc2 proteins in differentiated primary myoblasts from TA muscles of Cdk4WT and Cdk4R/R mice (n = 3 mice each group). GAPDH protein is shown as loading control. (L) mRNA expression levels of slow/oxidative muscle-specific transcripts (MyhcI and MyhcIIa) and fast/glycolytic muscle transcripts (MyhcIIx and MyhcIIb) in TA muscles of Cdk4WT and Cdk4R/R mice at 7 and 14 days after CTX injection (n = 5–6 mice each group). (M) Immunostaining of slow/oxidative muscle fibers (MyhcI positive) 7 days after CTX injection in TA muscles of Cdk4WT and Cdk4R/R mice (n = 5 mice each group). Scale bars: 500 μm. Between 5 and 6 mice per group were used in each experiment, unless mentioned otherwise. Data are shown as the mean ± SEM. *P < 0.05, *P < 0.01 by 2-tailed Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts